Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 10-2001 | 10-2000 | |
| Cash Flows From Operating Activities | ||
| Net Income | -1,287,700 | 868,100 |
| Depreciation Amortization | 197,800 | 146,200 |
| Income taxes - deferred | -438,900 | 332,000 |
| Accounts receivable | 339,300 | -158,700 |
| Accounts payable and accrued liabilities | -61,700 | 83,600 |
| Other Working Capital | 128,300 | -122,200 |
| Other Operating Activity | 1,217,900 | -898,100 |
| Operating Cash Flow | $95,000 | $250,900 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -230,800 | -375,300 |
| Net Acquisitions | 68,800 | -345,300 |
| Purchase Of Investment | -29,000 | N/A |
| Sale Of Investment | 222,000 | 196,500 |
| Investing Cash Flow | $31,000 | $-524,100 |
| Cash Flows From Financing Activities | ||
| Debt Issued | -35,800 | -32,500 |
| Common Stock Issued | 40,400 | 277,200 |
| Financing Cash Flow | $4,600 | $244,700 |
| Exchange Rate Effect | 700 | -3,700 |
| Beginning Cash Position | 217,300 | 279,000 |
| End Cash Position | 348,600 | 217,300 |
| Net Cash Flow | $131,300 | $-61,700 |
| Free Cash Flow | ||
| Operating Cash Flow | 95,000 | 250,900 |
| Capital Expenditure | -249,200 | -375,300 |
| Free Cash Flow | -154,200 | -124,400 |